News & Events
November 13, 2018
Critical Path for Alzheimer’s Disease 2018 Annual Meeting and Regulatory Science WorkshopNovember 13, 2018 Overview and Objectives: The Critical Path for Alzheimer’s Disease (CPAD) is a public-private partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process leading to treatments for neurodegenerative diseases that progress to dementia with the shared characteristics of Alzheimer disease (AD), the...
October 30, 2018
Webinar Recording Available: Acetaminophen-Induced Liver Toxicity Mechanisms, Diagnosis and TreatmentMembers of C-Path’s Predictive Safety Testing Consortium (PSTC) were among the featured facilitators and speakers of an educational webinar, sponsored and hosted by the Clinical and Translational Toxicology Specialty Section of the Society of Toxicology, on acetaminophen (APAP) induced liver toxicity. With a duration of 1 hour and 12 minutes, this Oct. 30, 2018 event...
October 24, 2018 - October 27, 2018
11th Clinical Trials on Alzheimer’s Disease (CTAD)The Clinical Trials on Alzheimer’s Disease (CTAD) conference is an important annual scientific meeting where latest developments and research results from clinical Alzheimer disease trials are shared and discussed. Researchers and participants from pharma, academia, patent-advocacy organizations and other groups are coming together in Barcelona, Spain, between October 24th and 27th. Each year, on behalf...
October 7, 2018 - October 10, 2018
9th Annual Conference of Pharmacometrics (ACoP9)The ninth Annual Conference of Pharmacometrics (ACoP9) is the annual scientific meeting of the International Society of Pharmacometrics. More than 650 researchers and participants from pharma, academia, and non-government organizations attended ACoP9 in San Diego between October 6th and 11th to exchange the latest research and application of quantitative methods to pharmaceutics. Members of the...
September 27, 2018 - September 28, 2018
Workshop on Evidence-Based Treatment Decisions in Transplantation Informs PRO and Patient-Focused Drug DevelopmentThe U.S. Food and Drug Administration (FDA) held a public workshop on September 27-28, 2018 at its White Oak Campus in Silver Spring, MD. titled “Evidence-Based Treatment Decisions in Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment.” The workshop was planned and presented in collaboration with the Transplant Therapeutics Consortium (TTC),...